Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Lung Neoplasms 4Stomach Neoplasms 3Uterine Cervical Neoplasms 1Smoking 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Platelet Glycoprotein IV Deficiency 1Pediatric Brain Tumor 1Pancreatic Cyst 1Ovarian Neoplasms 1Osteosarcoma 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Lymphoma 1Locally Advanced Pancreatic Cancer 1Gastrointestinal Neoplasms 1Fatty Liver 1Cysts 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

lutetium Lu 177 dotatate 10Everolimus 5lanreotide 4gallium Ga 68 dotatate 4Nivolumab 4Magnetic Resonance Spectroscopy 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3Temozolomide 3Somatostatin 3Capecitabine 3surufatinib 2pembrolizumab 2copper dotatate CU-64 2cabozantinib 2amino-acid, glucose, and electrolyte solution 2Specimen Handling 2Octreotide 2Lutetium-177 2Lutetium 2Injections 2Fluorodeoxyglucose F18 2Cyclophosphamide 2tivozanib 1talazoparib 1sintilimab 1repotrectinib 1lenvatinib 1guarana powder 1gadoteridol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuroendocrine Tumors × Tomography, X-Ray Computed × Clear all
NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡